Hyojin Chae
Papers
1
Total Citations
2
H-Index
1
About
Hyojin Chae is a clinical researcher advancing the frontiers of mass spectrometry and laboratory automation. Her work centers on the critical intersection of analytical chemistry and clinical diagnostics, with a particular focus on therapeutic drug monitoring. In her most cited study, "Evaluation of a Robotic Liquid Handler, Andrew+, for Sample Preparation for LC-MS/MS-Based Quantitation of Immunosuppressants in Whole Blood" (2023), Chae and her team pioneered the validation of an automated liquid handling system for preparing immunosuppressant drug samples. This work directly addresses a pressing need in transplant medicine: the accurate, high-throughput quantification of drugs like tacrolimus and cyclosporine to prevent organ rejection. By demonstrating that the Andrew+ robotic platform achieves precision and accuracy comparable to manual preparation while significantly reducing human error and hands-on time, Chae has provided a practical blueprint for modernizing clinical laboratories. Her research not only improves patient safety through more reliable drug monitoring but also enhances laboratory efficiency. With 2 citations already, this foundational study is poised to influence the widespread adoption of automation in clinical mass spectrometry, marking Chae as a key contributor to the next generation of precision laboratory medicine.
Research Focus
Key Achievements
Top Papers
- 1